Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP Monographs Will Follow International Format For Drug Impurities

Executive Summary

A new format for active pharmaceutical ingredient monographs will provide a more consistent approach to identify impurities, U.S. Pharmacopeia VP-Information & Standards Development Eric Sheinin, PhD, said

You may also be interested in...



FDA Fine Tunes Guidance Disclaimers, May Undertake Broad Review

FDA is considering undertaking a broad guidance clean-up effort, agency Chief Counsel Daniel Troy indicated May 16 during a Generic Pharmaceutical Association legal symposium in Washington, D.C

FDA Standardized NDA Review Format Includes Gender Analysis

Gender analysis is a required component of FDA's newly instituted standardized format for NDA reviews, the agency said April 18.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel